Literature DB >> 23676560

Biostatistics primer: what a clinician ought to know--prognostic and predictive factors.

Lorinda Simms1, Helen Barraclough, Ramaswamy Govindan.   

Abstract

Several prognostic factors in oncology have been established over the years, such as performance status, tumor size, and disease stage. The identification of prognostic and predictive factors is becoming increasingly important in medical research, particularly as scientific discoveries have led to better understanding of diseases and genetics, resulting in tailored therapy. Advances in drug discovery and better understanding of the mechanism of action, may also identify factors that may be prognostic and/or predictive. Prognostic or predictive factors may include patient characteristics such as age, ethnicity, sex, or smoking status, disease characteristics such as disease stage or nodal status, and molecular markers such as HER2 amplification and K ras mutation.It can be challenging to distinguish whether a factor is prognostic or predictive, based on what is reported in the literature. This article is intended to help the reader assess whether a factor is prognostic and/or predictive.

Entities:  

Mesh:

Year:  2013        PMID: 23676560     DOI: 10.1097/JTO.0b013e318292bdcd

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  11 in total

Review 1.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

2.  Interpretation of lung cancer study outcomes.

Authors:  Diego Cortinovis; Marida Abbate; Paolo Bidoli; Davide Pelizzoni; Stefania Canova
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 3.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 4.  Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Fergus Macbeth
Journal:  Thorax       Date:  2014-01-09       Impact factor: 9.139

5.  Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy.

Authors:  Giuseppe Cardillo; Sahar Mokhles; Norman Williams; Fergus Macbeth; Christopher Russell; Tom Treasure
Journal:  Br J Cancer       Date:  2015-09-15       Impact factor: 7.640

6.  Intraoperative detection of circulating tumor cells in pulmonary venous blood during metastasectomy for colorectal lung metastases.

Authors:  Uyen-Thao Le; Peter Bronsert; Francesco Picardo; Sabine Riethdorf; Benedikt Haager; Bartosz Rylski; Martin Czerny; Friedhelm Beyersdorf; Sebastian Wiesemann; Klaus Pantel; Bernward Passlick; Jussuf Thomas Kaifi; Severin Schmid
Journal:  Sci Rep       Date:  2018-06-08       Impact factor: 4.379

7.  Integrating sex and gender in studies of cardiac resynchronization therapy: a systematic review.

Authors:  Omar Dewidar; Irina Podinic; Victoria Barbeau; Dilan Patel; Alba Antequera; David Birnie; Vivian Welch; George A Wells
Journal:  ESC Heart Fail       Date:  2021-11-24

8.  Development and comparison of 1-year survival models in patients with primary bone sarcomas: External validation of a Bayesian belief network model and creation and external validation of a new gradient boosting machine model.

Authors:  Christina E Holm; Clare F Grazal; Mathias Raedkjaer; Thomas Baad-Hansen; Rajpal Nandra; Robert Grimer; Jonathan A Forsberg; Michael Moerk Petersen; Michala Skovlund Soerensen
Journal:  SAGE Open Med       Date:  2022-02-08

Review 9.  Pulmonary Metastasectomy for Colorectal Cancer: Recent Reports Prompt a Review of the Available Evidence.

Authors:  Tom Treasure
Journal:  Curr Colorectal Cancer Rep       Date:  2014

10.  Leveraging hybrid biomarkers in clinical endpoint prediction.

Authors:  Maliazurina Saad; Ik Hyun Lee
Journal:  BMC Med Inform Decis Mak       Date:  2020-10-07       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.